These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3920893)

  • 1. Prospective reimbursement for state-of-the-art medical practice: the case for invasive electrophysiologic evaluation.
    Saksena S; Greenberg E; Ferguson D
    Am J Cardiol; 1985 Apr; 55(8):963-7. PubMed ID: 3920893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of recurrent ventricular tachycardia: economic impact of therapeutic alternatives.
    Ferguson D; Saksena S; Greenberg E; Craelius W
    Am J Cardiol; 1984 Feb; 53(4):531-6. PubMed ID: 6421139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiologic evaluation for recurrent tachycardias: a financially endangered technique?
    Saksena S
    Int J Cardiol; 1985 Apr; 7(4):431-6. PubMed ID: 3921470
    [No Abstract]   [Full Text] [Related]  

  • 4. Supraventricular tachycardia in infancy: evaluation, management, and follow-up.
    Etheridge SP; Judd VE
    Arch Pediatr Adolesc Med; 1999 Mar; 153(3):267-71. PubMed ID: 10086404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of hospital cost and length of stay for patients undergoing electrophysiologic testing.
    Kay HR; Horowitz LN; Goldstein H; Tanida E; Mills LC; Greenspan AM; Spielman SR
    Am J Cardiol; 1987 Aug; 60(4):298-302. PubMed ID: 3113224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of class IC antiarrhythmic agents for the treatment of coexisting supraventricular and ventricular tachycardia.
    Rinkenberger RL; Naccarelli GV; Berns E; Dougherty AH
    Am J Cardiol; 1988 Aug; 62(6):44D-55D. PubMed ID: 3136636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
    Klein LS; Fineberg N; Heger JJ; Miles WM; Kammerling JM; Chang MS; Zipes DP; Prystowsky EN
    Am J Cardiol; 1988 May; 61(13):1024-30. PubMed ID: 3364357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost of tachyarrhythmia management.
    Hauser RG
    Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():35-7. PubMed ID: 3938256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-arrhythmia and electrophysiological effects of encainide in supraventricular tachycardias].
    Cassagneau B; Miquel JP; Puel JP; Mordant B; Kher A; Fauvel JM; Bounhoure JP
    Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():113-9. PubMed ID: 3938253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Electrophysiological evaluation of the treatment of patients with recurrent ventricular tachycardia].
    Mendoza I; Moleiro F; Castellanos A; Casal H; Arends E; Medina V
    Arch Inst Cardiol Mex; 1982; 52(4):301-11. PubMed ID: 7138133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of noninvasive arrhythmia induction techniques with electrophysiologic studies and evaluation of lorcainide in patients with symptomatic ventricular tachycardia.
    Somberg JC; Butler B; Flowers D; Tepper D; Maguire W; Willens H; Keren G; Miura D
    Am J Cardiol; 1984 Aug; 54(4):49B-54B. PubMed ID: 6465047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Will DRG payments creep into all US health insurance plans?
    Korcok M
    Can Med Assoc J; 1984 Apr; 130(7):912-5. PubMed ID: 6423253
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical electrophysiology, efficacy and safety of chronic oral cibenzoline therapy in refractory ventricular tachycardia.
    Rothbart ST; Saksena S
    Am J Cardiol; 1986 Apr; 57(11):941-6. PubMed ID: 3515898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug therapy of ventricular tachycardia: a cost comparison of randomized noninvasive and invasive approaches.
    Mitchell LB; Duff HJ; Miller CE; Eliasoph HP; Wyse DG
    Can J Cardiol; 1992 Jun; 8(5):487-94. PubMed ID: 1617528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluating the first German diagnosis-related groups (G-DRG) in cardiological patients: problems in the correct medical and economic grouping].
    Reinecke H; Bunzemeier H; Fürstenberg T; Rothenburger M; Böcker D; Scheld HH; Breithardt G; Roeder N
    Z Kardiol; 2003 Jul; 92(7):581-94. PubMed ID: 12883843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of electrophysiologic study for prediction and treatment of life-threatening arrhythmias.
    Sakurada H; Motomiya T; Hiraoka M
    Jpn Circ J; 1990 Oct; 54(10):1315-22. PubMed ID: 2277410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of an implantable antitachycardia pacemaker system for supraventricular or ventricular tachycardia.
    Saksena S; Pantopoulos D; Parsonnet V; Rothbart ST; Hussain SM; Gielchinsky I
    Am J Cardiol; 1986 Jul; 58(1):70-4. PubMed ID: 3728334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of the New Jersey all-payer DRG system.
    Rosko MD; Broyles RW
    Inquiry; 1986; 23(1):67-75. PubMed ID: 2937731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flecainide: electrophysiologic and antiarrhythmic properties in refractory ventricular tachycardia.
    Platia EV; Estes M; Heine DL; Griffith LS; Garan H; Ruskin JN; Reid PR
    Am J Cardiol; 1985 Apr; 55(8):956-62. PubMed ID: 3984883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selected results from an evaluation of the New Jersey Diagnosis-Related Group System.
    May JJ; Wasserman J
    Health Serv Res; 1984 Dec; 19(5):547-59. PubMed ID: 6438023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.